Jonathan Silverstein

Managing Partner at OrbiMed · Joined 1999

View Live Interactive Profile →

Biography

Jonathan Silverstein joined OrbiMed in 1999 to focus on private equity and structured transactions in small capitalization public biotechnology and medical device companies. OrbiMed's site now describes him as a former Managing Partner and current Executive Partner. He is co-founder and President of The Silverstein Foundation for Parkinson's with GBA, and he currently serves on the board of Vanqua Bio. He holds a J.D. and an M.B.A. from the University of San Diego and a B.A. in Economics from Denison University.

Education

Previous Experience

Notable Investments

Vanqua BioIntercept PharmaceuticalsAdicet BioInsuletGiven ImagingEnobia Pharma

Board Seats

Career Timeline

1989
Graduated from Denison University.
1999
Joined OrbiMed to focus on private equity and structured transactions in small capitalization public biotechnology and medical device companies.
2012
Joined the board of Intercept Pharmaceuticals alongside its $30 million Series C financing led by OrbiMed.
2016
Joined the board of Adicet Bio following its $51 million Series A financing.
null
Co-founded The Silverstein Foundation for Parkinson's with GBA and serves as its President.

Sources & References

OrbiMed - Jonathan T. Silverstein, J.D. ↗Vanqua Bio - Jonathan Silverstein, J.D. ↗Vanqua Bio - Board of Directors ↗Intercept Pharmaceuticals Closes $30 Million Series C Financing ↗Adicet Bio Announces Closing of $51 Million Series A Financing ↗Denison University - Jonathan Silverstein '89 Awarded Alumni Citation ↗Adicet Bio - Leadership and Board of Directors ↗